Temanogrel
WebTemanogrel hydrochloride is a serotonin antagonist and anti-platelet agent. MedKoo Biosciences, Inc. Tel: +1-919-636-5577 Fax: +1-919-980-4831 Email: [email protected] WebTo assess the effect of temanogrel on selected coronary physiology indices and angiographic measures following PCI 2. To assess the effect of temanogrel on myocardial injury following PCI; 3. To assess the pharmacokinetics (PK) of temanogrel and its active metabolites AR295980 (M1) and AR295981 (M2) in subjects undergoing PCI; 4.
Temanogrel
Did you know?
WebTemanogrel, is a highly selective 5-HT2A receptor antagonist with a Ki of 4.9 nM. Temanogrel also inhibits inositol phosphate accumulation with an IC50 of 5.2 nM. Temanogrel exhibits potent inhibition of serotonin mediated amplification of ADP-stimulated human and dog platelet aggregation (IC50=8.7 and 23.1 nM, respectively Web14 apr 2024 · A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention September 8, 2024 updated by: Arena Pharmaceuticals.
Web29 nov 2012 · Agreement Enables Clinical Development of Temanogrel to Resume with Ildong Funding. SAN DIEGO, CA, USA I November 28, 2012 I Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has entered into a co-development and license agreement with Ildong Pharmaceutical Co., Ltd., for temanogrel, Arena's internally … Web8 giu 2024 · Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO) Shared by Ken Dropiewski on June 8, 2024. More in Peripheral/Endo: Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device November 22, 2024;
WebWelcome to Lead Sciences! For Research Use Only! [email protected] +31 (0)704067069 Login
Web28 nov 2012 · Temanogrel is an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases, and has completed single- and multiple-ascending dose Phase 1 trials in healthy ...
Web9 giu 2024 · Arena Pharmaceuticals, Inc. ARNA announced that it has dosed the first patient in a phase II study evaluating its coronary candidate, temanogrel. The study is … driving school in brevard county floridaWeb丁香通为您提供Sigma货号T9126商品详情介绍:价格:¥744,货号:T9126-100ML,CAS号:538-23-8,品牌:Sigma,详见丁香通Sigma货号T9126商品详情页; driving school in bydgoszczhttp://www.cnreagent.com/s/sv213004.html driving school in bunbury waWebUno studio per valutare l'effetto del temanogrel orale sul flusso sanguigno digitale in partecipanti adulti con fenomeno di Raynaud secondario alla sclerosi sistemica Uno … driving school in bristolWeb13 giu 2016 · Temanogrel, also known as APD791, is a highly selective 5-hydroxytryptamine2A receptor inverse agonist under development for the treatment of … driving school in buffalo nyWebTemanogrel is a highly selective 5-HT2A receptor antagonist with a Ki of 4.9 nM. Temanogrel inhibits inositol phosphate accumulation with an IC50 of 5.2 nM. Temanogrel exhibits potent inhibition of serotonin mediated amplification of ADP-stimulated human and dog platelet aggregation (IC50=8.7 and 23.1 nM, respectively) [1]. driving school in buford gaWebTemanogrel, also known as APD791, is a highly selective 5-hydroxytryptamine2A receptor inverse agonist under development for the treatment of arterial thrombosis. Next day … driving school in caboolture